Nuvation Bio (NUVB) Current Assets (2023 - 2025)
Historic Current Assets for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $577.5 million.
- Nuvation Bio's Current Assets rose 222.04% to $577.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $577.5 million, marking a year-over-year increase of 222.04%. This contributed to the annual value of $526.3 million for FY2024, which is 1462.91% down from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Current Assets is $577.5 million, which was up 222.04% from $623.2 million recorded in Q2 2025.
- Nuvation Bio's Current Assets' 5-year high stood at $652.6 million during Q1 2023, with a 5-year trough of $475.6 million in Q1 2025.
- Over the past 3 years, Nuvation Bio's median Current Assets value was $608.1 million (recorded in 2024), while the average stood at $590.4 million.
- Over the last 5 years, Nuvation Bio's Current Assets had its largest YoY gain of 613.72% in 2025, and its largest YoY loss of 2178.88% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Current Assets stood at $616.4 million in 2023, then fell by 14.63% to $526.3 million in 2024, then rose by 9.74% to $577.5 million in 2025.
- Its last three reported values are $577.5 million in Q3 2025, $623.2 million for Q2 2025, and $475.6 million during Q1 2025.